Chest X-ray vs ultra-low-dose chest CT in adults with possible pneumonia in the ER

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In adults presenting to the emergency department with suspected community-acquired pneumonia, researchers compare total staff time spent per imaging episode between standard chest radiography and ultra-low-dose CT. The study is a single-center, two-period observational time-and-motion analysis at Hospital Sønderjylland in Aabenraa. CXR data are collected from 2025 through mid-2027, while the ULDCT arm begins in late 2026, with the main outcome being staff minutes per imaging episode computed from radiology timestamps and in-room time. Analyses include nonparametric comparison and bootstrapped confidence intervals, with adjustments via quantile regression. The goal is to understand workflow impact of substituting ULDCT for CXR in the ED for potential CAP cases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients presenting to the emergency department during daytime weekday hours in whom CAP is a differential diagnosis, and who are able to undergo the assigned imaging examination.

Exclusion Criteria:

* Patients requiring immediate imaging for a critical condition (for example suspected pneumothorax).
* Bariatric patients exceeding the technical limits of the scanner
* Pregnancy
* Patients requiring additional imaging beyond the chest (for example abdominal CT)
* Severe dementia, or need for sedation to complete imaging
* Patients requiring mechanical ventilation.
* Patients requiring accompaniment by medical staff during transport

Where it's running

• Hospital Sønderjylland
  Aabenraa, Denmark Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lefamulin Post-Market Surveillance in Community-Acquired Pneumonia

  This study follows people with community-acquired pneumonia who are being treated with lefamulin to see how it works in real-world clinical use.

  Recruiting Marubeni Pharmaceuticals (Suzhou) Co., Ltd. · Beijing, Beijing Municipality · NCT07697885

• Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates

  This project will test whether giving primary care doctors and pharmacists extra information about circulating viruses plus a shared protocol helps shorten antibiotic courses for patients with common respiratory infections.

  Recruiting University Hospital, Caen · Caen · NCT07359287

• Improving treatment for children with community-acquired pneumonia in emergency rooms

  This project tests a new care pathway to see if emergency departments can safely give fewer antibiotics to children aged 6 months–18 years with non-severe community-acquired pneumonia who are sent home.

  Recruiting at 2 sites McMaster University · Calgary, Alberta and 5 other locations · NCT07099976

• Antibiotic strategies for young children with pneumonia in outpatient care

  This trial will see if a 'watch-and-wait' Safety Net Antibiotic Prescribing (SNAP) approach can safely reduce antibiotic use compared with immediate antibiotics in children aged 12 months to under 6 years with mild community-acquired pneumonia.

  Recruiting at 4 sites Ann & Robert H Lurie Children's Hospital of Chicago · Atlanta, Georgia and 3 other locations · NCT06986148

• Hydrocortisone vs prednisolone for severe community-acquired pneumonia

  This trial tests whether hydrocortisone or prednisolone helps adults with severe community-acquired pneumonia live longer and have fewer side effects within 30 days.

  Recruiting at 14 sites Phase 4 Copenhagen Respiratory Research · Rønne, Bornholm and 13 other locations · NCT06892197

• ARGONAUT: Italian registry of pneumonia in people with weakened immune systems

  This project will collect clinical and lab data to see how community-acquired pneumonia affects hospitalized adults with weakened immune systems.

  Recruiting Societa Italiana di Pneumologia · Milan, Milano · NCT06755814

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.